[
  {
    "ts": null,
    "headline": "Undercovered Dozen: Energy Transfer, Vertical Aerospace, QuantumScape And More",
    "summary": "Discover 12 underrated stocks with strong buy ratings and unique growth potential.",
    "url": "https://finnhub.io/api/news?id=422929f44e2a3092d2e47520e9174006b8123b32f294f45067af05492c2b7034",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757692619,
      "headline": "Undercovered Dozen: Energy Transfer, Vertical Aerospace, QuantumScape And More",
      "id": 136727992,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1924490980/image_1924490980.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Discover 12 underrated stocks with strong buy ratings and unique growth potential.",
      "url": "https://finnhub.io/api/news?id=422929f44e2a3092d2e47520e9174006b8123b32f294f45067af05492c2b7034"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer's Late-Stage Pipeline Fuels Long-Term Growth Prospects",
    "summary": "Pfizer's late-stage pipeline, from oncology blockbusters to mRNA vaccines, positions it for long-term growth despite recent setbacks.",
    "url": "https://finnhub.io/api/news?id=33d169e27939dbf9a609188009941af1bac2f2e42969cabee6e4b5d0ab5b71b0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757690700,
      "headline": "Pfizer's Late-Stage Pipeline Fuels Long-Term Growth Prospects",
      "id": 136726597,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Pfizer's late-stage pipeline, from oncology blockbusters to mRNA vaccines, positions it for long-term growth despite recent setbacks.",
      "url": "https://finnhub.io/api/news?id=33d169e27939dbf9a609188009941af1bac2f2e42969cabee6e4b5d0ab5b71b0"
    }
  },
  {
    "ts": null,
    "headline": "Meet 16 Ideal \"Safer\" September Dividend Dogs Of The S&P500",
    "summary": "Sixteen of the thirty-eight highest-yield, 'safer' S&P 500 dividend stocks are highlighted as ready to buy, with adequate free cash flow supporting payouts. Read more here.",
    "url": "https://finnhub.io/api/news?id=e89bdeb12c895633e371b40b6f921a2b90b1cd333291489283aadf4d76639e46",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757689939,
      "headline": "Meet 16 Ideal \"Safer\" September Dividend Dogs Of The S&P500",
      "id": 136727554,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1290322161/image_1290322161.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Sixteen of the thirty-eight highest-yield, 'safer' S&P 500 dividend stocks are highlighted as ready to buy, with adequate free cash flow supporting payouts. Read more here.",
      "url": "https://finnhub.io/api/news?id=e89bdeb12c895633e371b40b6f921a2b90b1cd333291489283aadf4d76639e46"
    }
  },
  {
    "ts": null,
    "headline": "BMY-BioNTech Partnership: A Potential Catalyst for Long-Term Gains?",
    "summary": "Bristol Myers and BioNTech report strong mid-stage lung cancer trial data for pumitamig, showing high response rates and manageable safety.",
    "url": "https://finnhub.io/api/news?id=e681ff209d9aa7eaa0aab107b88f7f7ad0e519ad21a10fb65d723046e50cab70",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757686080,
      "headline": "BMY-BioNTech Partnership: A Potential Catalyst for Long-Term Gains?",
      "id": 136711328,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol Myers and BioNTech report strong mid-stage lung cancer trial data for pumitamig, showing high response rates and manageable safety.",
      "url": "https://finnhub.io/api/news?id=e681ff209d9aa7eaa0aab107b88f7f7ad0e519ad21a10fb65d723046e50cab70"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know",
    "summary": "Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
    "url": "https://finnhub.io/api/news?id=828fc7be6d257f6d9970594c135194dbc2998c915b2fef4b48e00d9bce78c288",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757685603,
      "headline": "Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know",
      "id": 136711453,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
      "url": "https://finnhub.io/api/news?id=828fc7be6d257f6d9970594c135194dbc2998c915b2fef4b48e00d9bce78c288"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Is Growing More Reliant on Vaccines as Controversies Swirl",
    "summary": "For U.S. Big Pharma companies, vaccines have largely been an afterthought. But by 2030, they could be a quarter of Pfizer’s revenue.",
    "url": "https://finnhub.io/api/news?id=c9856317978cc0374201e534ece3e531bd07b9ea156ab6692f3248a096ffc96a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757664000,
      "headline": "Pfizer Is Growing More Reliant on Vaccines as Controversies Swirl",
      "id": 136711232,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "For U.S. Big Pharma companies, vaccines have largely been an afterthought. But by 2030, they could be a quarter of Pfizer’s revenue.",
      "url": "https://finnhub.io/api/news?id=c9856317978cc0374201e534ece3e531bd07b9ea156ab6692f3248a096ffc96a"
    }
  },
  {
    "ts": null,
    "headline": "3 Reasons to Sell BMY and 1 Stock to Buy Instead",
    "summary": "What a brutal six months it’s been for Bristol-Myers Squibb. The stock has dropped 20.5% and now trades at $47.55, rattling many shareholders. This may have investors wondering how to approach the situation.",
    "url": "https://finnhub.io/api/news?id=1eb856c7f8e3ac696ef92da9e2e1f19b87ba762fb2d235dc243aa1a101543fd5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757653386,
      "headline": "3 Reasons to Sell BMY and 1 Stock to Buy Instead",
      "id": 136711455,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "What a brutal six months it’s been for Bristol-Myers Squibb. The stock has dropped 20.5% and now trades at $47.55, rattling many shareholders. This may have investors wondering how to approach the situation.",
      "url": "https://finnhub.io/api/news?id=1eb856c7f8e3ac696ef92da9e2e1f19b87ba762fb2d235dc243aa1a101543fd5"
    }
  },
  {
    "ts": null,
    "headline": "Lonza Appoints New Operations Head, Creates Chief Quality Officer Role",
    "summary": "Lonza Appoints New Operations Head, Creates Chief Quality Officer Role",
    "url": "https://finnhub.io/api/news?id=cf33aab60dfc331d328b489ef3777864782094dfd19a9895b8ce6bb7e7bda49e",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757651100,
      "headline": "Lonza Appoints New Operations Head, Creates Chief Quality Officer Role",
      "id": 136716241,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "Lonza Appoints New Operations Head, Creates Chief Quality Officer Role",
      "url": "https://finnhub.io/api/news?id=cf33aab60dfc331d328b489ef3777864782094dfd19a9895b8ce6bb7e7bda49e"
    }
  }
]